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Because commercial products are hardly or no longer available due to the coronavirus disease 
(COVID-19) pandemic, alcohol-based hand rub for-
mulations for hygienic and surgical hand treatment 
published by the World Health Organization (WHO) 
in 2009 (1) for local production in developing coun-
tries are now being produced for use in hospitals 
worldwide. As shown previously (2), neither the 
formulation based on ethanol 80% vol/vol (WHO I) 
nor that based on isopropanol 75% vol/vol (WHO 
II), meets the efficacy requirements of the European 
Norm (EN) 12791 (3), which must be fulfilled to ob-
tain approval as a surgical hand preparation in Eu-
rope. Each WHO-recommended formulation is also 
insufficient for hygienic hand antisepsis when 3 mL 
is applied for 30 seconds (4) according to the test 
method described in EN 1500 (5). The requirements 
can be met only if the volume is doubled (6 mL) and 
exposure is extended to 60 seconds (4). But sufficient 
efficacy has been achieved by using modified WHO 
formulations with an increased alcohol concentration 
of 80% wt/wt ethanol or 75% wt/wt isopropanol at 3 
mL for 30 seconds (4). 
On the basis of those results, we modified both 
WHO formulations by increasing their alcohol con-
centrations through changing their volume percent-
ages into weight percentages and by prolonging the 
duration of application from 3 to 5 minutes. These 
modifications have been shown to render the imme-
diate effects of both formulations noninferior to the 
reference of EN 12791, but this improvement was not 
observed for the so-called 3-hour effect (i.e., 3 hours 
after hand antisepsis) (6). Because the high glycerol 
concentration (1.45% vol/vol) of the original formu-
lations has been shown to exert a negative influence 
on the 3-hour efficacy of alcohols (7), we performed 
further studies by reducing the glycerol content of the 
WHO formulations by 50%. By increasing the alcohol 
concentration by ≈5% and reducing glycerol concen-
trations to 0.725%, both modified WHO formulations 
meet the efficacy requirements of EN 12791 when 
used for 5 minutes (8). Although both new formula-
tions were successfully tested for a 5-minute appli-
cation, our suggestions for improving efficacy were 
not accepted by the WHO because the common dura-
tion for surgical hand preparation in most hospitals 
is 3 minutes. Furthermore, no information on dermal 
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As a result of the coronavirus disease pandemic, com-
mercial hand hygiene products have become scarce and 
World Health Organization (WHO) alcohol-based hand 
rub formulations containing ethanol or isopropanol are 
being produced for hospitals worldwide. Neither WHO 
formulation meets European Norm 12791, the basis for 
approval as a surgical hand preparation, nor satisfies Eu-
ropean Norm 1500, the basis for approval as a hygienic 
hand rub. We evaluated the efficacy of modified formu-
lations with alcohol concentrations in mass instead of 
volume percentage and glycerol concentrations of 0.5% 
instead of 1.45%. Both modified formulations met stan-
dard requirements for a 3-minute surgical hand prepara-
tion, the usual duration of surgical hand treatment in most 
hospitals in Europe. Contrary to the originally proposed 
WHO hand rub formulations, both modified formulations 
are appropriate for surgical hand preparation after 3 min-
utes when alcohol concentrations of 80% wt/wt ethanol 
or 75% wt/wt isopropanol along with reduced glycerol 
concentration (0.5%) are used.
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 26, No. 9, September 2020 2065
tolerability and healthcare workers’ acceptance of 
these modified formulations was available.
In 2019, Menegueti et al (9) showed that a modi-
fied WHO I formulation containing only 0.5% glycerol 
led to better ratings of skin tolerance than the original 
WHO formulation containing 1.45% or a modification 
containing 0.75% glycerol. Because all such alterna-
tive formulations require testing for not only dermal 
tolerability but also for bactericidal performance, we 
investigated the efficacy of these modified WHO for-
mulations (mass instead of volume percentage etha-
nol or isopropanol and 0.5% instead of 1.45% glyc-
erol) according to EN 12791 (3), with an application 
duration of 3 minutes, as commonly used in surgical 
theaters in Europe.
Materials and Methods
We used 2 formulations in this study. WHO I modi-
fied comprised ethanol (for analysis; Merck KGaA, 
https://www.emdgroup.com) 80% wt/wt, hydrogen 
peroxide (for analysis; Merck) 0.125% vol/vol, and 
glycerol (for analysis; Merck) 0.5% vol/vol. WHO II 
modified comprised isopropanol (for analysis; Mer-
ck) 75% wt/wt, hydrogen peroxide 0.125% vol/vol, 
and glycerol 0.5% vol/vol. For the reference alcohol 
of EN 12791, we used N-propanol (for analysis; Mer-
ck) 60% (vol/vol) without additions (3).
We recruited 24 volunteers from the Institute for 
Hygiene and Applied Immunology, Medical Univer-
sity of Vienna (Vienna, Austria), to participate in the 
study. Exclusion criteria were age <18 years and skin 
breaks on hands (e.g., cuts, abrasions or other skin 
disorders). Nails were short and clean and volunteers 
agreed to not use any antibacterial soap or other an-
tibacterial substance during the trial, starting from 1 
week before testing. Volunteers were also asked to 
not use any hand rub or hand cream on trial days. 
All volunteers provided written informed consent. 
The study protocol was approved by the institutional 
ethics committee of the Medical University of Vienna 
(ethical vote no. 2092/2019).
Culture media were as described in EN 12791 (3). 
For sampling and dilution fluids, we used tryptic soy 
broth (CASO broth; Merck). For counting plates, we 
used tryptic soy agar (CASO agar; Merck). Neutral-
izing agents were not necessary for any of the tested 
modified WHO formulations because even dilution 
in pure broth without supplement in previous valida-
tion tests has been shown to neutralize any antimicro-
bial effect (4).
We compared the efficacy of the modified WHO 
formulations with that of the standardized reference 
surgical hand treatment described in EN 12791. We 
used a Latin-square design with 3 groups, each with 
8 randomly allocated volunteers, and as many experi-
mental runs as there were formulations, including the 
reference. In every run, we tested all hand treatment 
procedures concurrently. At the end of the third test 
run, every volunteer had used each formulation once. 
We spaced test runs apart by 1 week to allow rever-
sion of normal skin flora.
We used the test method described in EN 12791 
(3). In brief, after a preparatory hand wash for 1 min-
ute with 5 mL of 20% nonmedicated soap applied onto 
wet hands to remove transient bacterial flora and any 
other soil, participants rinsed their hands under run-
ning tap water and dried them with soft paper tow-
els. Pretreatment values were established by rubbing 
and kneading the fingertips, including the thumbs, of 
both hands for 1 minute at the base of a petri dish (di-
ameter 9 cm) containing 10 mL of sampling fluid, one 
for each hand. Subsequently, surgical hand antisepsis 
was performed according to the standardized hand 
rub procedure of EN 12791 by applying and rubbing 
as many 3-mL portions of the study formulations (i.e., 
WHO I modified, WHO II modified, or reference) 
onto both hands up to the wrists as necessary to keep 
the hands wet for 3 minutes. 
According to EN 12791, the efficacy of a preop-
erative hand procedure is determined immediately 
and 3 hours after hand antisepsis. Thus, to assess the 
posttreatment values of a formulation, we sampled 
one randomly selected hand as described for the pre-
treatment values immediately after hand antisepsis 
(immediate effect). The other hand was gloved and 
sampled 3 hours later to assess the 3-hour effect. We 
performed quantitative surface cultures from all sam-
pling fluids and dilutions on tryptic soy agar, incu-
bated counting plates for a total of 48 hours at 36°C ± 
1°, and counted colony-forming units. 
For statistical analyses, we expressed all colony 
counts per mL of sampling fluid as decadic loga-
rithms.. From the intra-individual differences be-
tween log10 pretreatment minus log10 posttreatment 
values, we calculated individual log10 reduction fac-
tors separately for immediate and 3-hour effects. We 
tested pretreatment values of study formulations and 
the reference formulation for significant differences 
by means of the Friedman analysis of variance with an 
agreed significance level of p = 0.05. Subsequently, we 
tested the differences between the log10 reduction fac-
tors from each study formulation and the appropriate 
values of the reference for significance by a nonpara-
metric noninferiority test according to Hodges-Lehm-
ann. We rejected inferiority of a study formulation 
and assumed noninferiority if the Hodges-Lehmann 
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upper 97.5% confidence limits for the differences in 
log10 bacterial reductions between study formulations 
and reference treatment were smaller than the agreed 
inferiority margin of 0.75 log10 (immediate effect) or 
0.85 log10 (3-hour effect). We set the level of signifi-
cance at p = 0.025 (1-sided). Furthermore, we used the 
Wilcoxon matched-pairs, signed-ranks test to test for 
a suspected sustained effect at p = 0.01 (1-sided) if—
as concluded from a higher mean log10 reduction—a 
study formulation was suspected to be more effica-
cious than the reference antisepsis procedure 3 hours 
after antisepsis.
Results
We observed no significant differences between the 
means of the log10 pretreatment bacterial counts for 
the immediate and 3-hour efficacy tests. Hence, the 
baseline for each study formulation can be consid-
ered equivalent.
Overall, immediate effects were comparable to 
that of the reference alcohol of EN 12791; typical mag-
nitude was mean log10 reductions of >2.00 (Table). 
Each modified formulation was even more effective 
than the reference alcohol immediately after hand 
antisepsis. Each modified formulation also met the 
3-hour efficacy requirements of EN 12791. The mean 
log10 bacterial reduction of the formulation based on 
isopropanol was greater by 0.15 log10 than that of the 
reference alcohol, but this difference was not signifi-
cant (p = 0.01 by Wilcoxon matched-pairs signed-
ranks test), so sustained efficacy cannot be confirmed.
Discussion
The COVID-19 pandemic has led to scarcity of com-
mercial hand antisepsis agents, and healthcare insti-
tutions worldwide are seeking alternatives. Since the 
end of February 2020, pharmacies in Europe have 
been producing the WHO-recommended formula-
tions either for sale or as donations for personal use 
by the general population or use in healthcare set-
tings. Use of hygienic hand preparations made with 
the original WHO-recommended formulations might 
be justifiable to prevent infection or transmission of 
pathogens outside patient care. However, to be ap-
proved in Europe, preparations for hygienic hand 
antisepsis used in healthcare facilities must meet the 
bactericidal efficacy requirements of EN 1500 (5) un-
der practical use conditions. Both WHO-recommend-
ed formulations failed the EN 1500 requirements with 
use of 3 mL for 30 seconds, the common duration of 
application in hospitals in Europe (4). Sufficient bac-
tericidal efficacy could be achieved with the original 
WHO-recommended formulation with 6 mL in 60 
seconds or with 3 mL in 30 seconds when modified 
formulations with increased alcohol concentrations of 
80% wt/wt ethanol or 75% wt/wt isopropanol were 
used (4). In general, a shortening of the necessary ex-
posure time may help medical personnel comply with 
hand hygiene standards. A recent study (A. Kratzel 
et al., unpub. data, https://www.biorxiv.org/conte
nt/10.1101/2020.03.10.986711v1) showed that severe 
acute respiratory coronavirus 2 can be inactivated 
within 30 seconds by both WHO-recommended for-
mulations but also by modifications as proposed by 
us in 2013 (8) or used by Allegranzi et al. (10) in a 
before–after intervention cohort study.
The use of WHO-recommended formulations in 
hospitals, including for surgical hand preparation, is 
paramount despite the lack of commercial agents. In 
Europe, before a product is allowed to be used for sur-
gical hand preparation, its efficacy must be evaluated 
in the laboratory on the hands of volunteers accord-
ing to EN 12791 (3), the most stringent available in 
vivo test method for efficacy testing. This testing en-
sures that results are generated under controlled con-
ditions but also under as near as possible practical in 
vivo conditions. The bacterial reduction is measured 
directly after hand antisepsis on one hand (immedi-
ate effect) and after 3 hours on the other (gloved) hand 
(3-hour effect). According to the requirements of the 
norm, a formulation shall not be significantly less ef-
ficacious than a reference procedure at both times (i.e., 
immediately and 3 hours after application). The 2009 
WHO guideline reported that WHO I did not pass EN 
12791 under 2 laboratory testing conditions and WHO 
II under 1 of 2 laboratory testing conditions (1). Even 
 
Table. Immediate and 3-hour effects after 3-minute application of modified WHO formulations compared with 3-minute applications of 
reference surgical hand antiseptic treatment according to European Norm 12791 
Formulation 
Immediate effect 
 
3-hour effect 
Mean log10 
reduction 
Hodges-Lehmann upper 
97.5% confidence limit† 
Mean log10 
reduction 
Hodges-Lehmann upper 
97.5% confidence limit‡ 
WHO I modified with ethanol 2.99  1.03 0.03 n.i.  1.95  0.97 0.55 n.i. 
WHO II modified with isopropanol 2.95  1.03 0.23 n.i.  2.17  1·48 0.47 n.i. 
Reference 2.64  0.93 Not applicable  2.02  1.06 Not applicable 
*n = 24 study participants. n.i., noninferior versus reference; WHO, World Health Organization. 
†With an agreed inferiority margin of 0.75 log10. 
‡With an agreed inferiority margin of 0.85 log10. 
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prolonging the duration of application to 5 minutes, 
the longest duration allowed by EN 12791, did not 
achieve a favorable outcome for the original WHO for-
mulations (2,6). Increasing the alcohol concentration 
of both formulations by ≈5% (by changing to weight 
percentage concentrations) rendered the immediate ef-
fect of the 2 formulations noninferior to the reference; 
unfortunately, the 3-hour effect was still significantly 
less effective than the reference alcohol (6). The reason 
for these results was attributed to the high concentra-
tion of glycerol (1.45% vol/vol). Although the 3-hour 
effects of each formulation with reduced glycerol con-
tent (0.725%) were rendered noninferior to the refer-
ence, glycerol-free preparations were even more ef-
fective than reference EN 12791. We have been able to 
show how the WHO formulations can be improved to 
meet the European standards; however, our proposals 
have not yet been endorsed. One of the arguments giv-
en was the lack of data on acceptance and tolerability 
for the modified formulations. Another argument was 
the necessary application duration of 5 minutes for 
surgical hand preparation, which does not correspond 
with common practice.
Frequent use of alcohol-based hand rubs can 
cause skin dryness unless emollients or humec-
tants such as glycerol are added to the formulation. 
A recent study (9) evaluated the skin tolerability of 
healthcare workers to the original WHO formulation 
containing 1.45% glycerol against 3 other concentra-
tions (0%, 0.5%, and 0.75%) of glycerol in a tropical 
climate healthcare setting. Dermal application of glyc-
erol, a trihydroxy alcohol, increases the endogenous 
delivery of glycerol with improvement of stratum cor-
neum hydration, skin barrier function, and mechani-
cal properties. It also inhibits stratum corneum lipid 
phase transition, protection against irritating stimuli, 
and enhancement of desmosomal degradation (11). 
A modified WHO formulation containing only 0.5% 
glycerol leads to better ratings of skin tolerance than 
the original formulation and may therefore offer the 
best balance between skin tolerance and antimicro-
bial efficacy. In addition, it is useful to have the same 
alcohol-based hand rub formulation in the surgical 
setting and in other medical settings, especially if 
products are scarce. Because glycerol availability is 
also critical during the current pandemic, lowering 
the glycerol concentration might improve availability 
of these alcohol-based formulations in areas with lim-
ited supplies, such as developing countries.
In this study, we were able to show, once again, 
that the effect on the resident skin flora of the original 
WHO formulations can be improved if the concentra-
tion of the alcohols is increased by using weight in-
stead of volume percentage. In addition, by further 
reducing the glycerol content from 1.45% to 0.725% 
or to 0.50%, the 3-hour effects of each formulation can 
be improved to such an extent that the requirement 
of the European test standard is already ensured af-
ter 3 minutes of application. Although the criteria for 
use as a product regulated by the US Food and Drug 
Administration differ from the EN requirements, 
these results could also be of interest to US health-
care providers. Reductions achieved with the modi-
fied formulations were >1 log10 step higher than those 
achieved with the original WHO-recommended for-
mulations when applied for 3 minutes for both im-
mediate and 3-hour effects (Figure).
On the basis of these results and considering the 
current situation, we believe that the original WHO 
formulations should be urgently reconsidered. We 
therefore recommend a modification of the WHO I 
formulation with 80% wt/wt ethanol, 0.125% vol/vol 
hydrogen peroxide, and 0.50% vol/vol glycerol and 
a modification of the WHO II formulation with 75% 
wt/wt isopropanol, 0.125% vol/vol hydrogen perox-
ide, and 0.50% vol/vol glycerol.
Acknowledgments
We thank Martina Weinlich for her excellent technical 
help.
Figure. Comparison of the immediate and 3-hour effects of the 
WHO-recommended (WHO I and WHO II) and modified (WHO I 
modified and WHO II modified) formulations among 24 volunteers 
after a 3-minute surgical hand preparation according to European 
Norm 12791 (3). WHO I: ethanol 80% vol/vol + glycerol 1.45% vol/
vol + hydrogen peroxide 0.125% vol/vol. WHO II: isopropanol 75% 
vol/vol + glycerol 1.45% vol/vol + hydrogen peroxide 0.125% vol/
vol. WHO I modified: ethanol 80% wt/wt + glycerol 0.5% vol/vol + 
hydrogen peroxide 0.125% vol/vol. WHO II modified: isopropanol 
75% wt/wt + glycerol 0.5% vol/vol + hydrogen peroxide 0.125% 
vol/vol. WHO, World Health Organization.
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EID podcast
Developing  
Biological  
Reference Materials 
to Prepare  
for Epidemics
Visit our website to listen:
https://go.usa.gov/xyfJX
Having standard biological reference materials, 
such as antigens and antibodies, is crucial for 
developing comparable research across inter-
national institutions. However, the process of 
developing a standard can be long and difficult. 
In this EID podcast, Dr. Tommy Rampling, a 
clinician and academic fellow at the Hospital 
for Tropical Diseases and University College 
in London, explains the intricacies behind the 
development and distribution of biological 
reference materials. 
